🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This phase III trial studies combination chemotherapy with or without lesta...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2008-01-15
Trial ID
NCT00557193
Treatments Being Tested
PALETTE is a perpetual adaptive platform to efficiently study sepsis interv...
Status
Recruiting
Location
CHU Dijon - infectiologie
Start Date
2026-07-09
Trial ID
NCT06381661
Treatments Being Tested
Patients less than or equal to 21 years old with high-risk hematologic mali...
Status
Active Not Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2019-01-31
Trial ID
NCT03849651
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
CCOP - Mayo Clinic Scottsdale Oncology Program
Start Date
2002-09-17
Trial ID
NCT00046930
Treatments Being Tested
This is a phase 2, prospective, multicenter, randomized, double blind, plac...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-09
Trial ID
NCT04519424
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Veterans Affairs Medical Center - Palo Alto
Start Date
2006-09-26
Trial ID
NCT00274924
This is a Multicenter, Double-Blind, Randomized, Comparative Efficacy and S...
Status
Completed
Location
Mylan Investigational Site 3502
Start Date
2015-03
Trial ID
NCT02467868
Healthy donors are commonly mobilized with granulocyte colony-stimulating f...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2026-03-01
Trial ID
NCT07423728
Treatments Being Tested